29-01-2025 | Androgens | Letter to the Editor
Pembrolizumab added to neoadjuvant chemotherapy may improve pathological complete response in androgen-receptor positive and low tumor-infiltrating lymphocytes triple-negative breast cancer patients
Published in: Breast Cancer
Login to get access